FR0012333284
FR0012333284
ABIVAX
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | -- | -- | -- |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 246.056.000 | 172.984.000 | 42.2% | |
| Operating Income | -246.056.000 | -172.984.000 | 42.2% |
| Pretax Income | -330.254.000 | -176.242.000 | 87.4% |
| Net Income Common Stockholders | -336.102.000 | -176.242.000 | 90.7% |
| -- | -- | -- | |
| -- | -- | -- |